NEPH is expected to report earnings to fall 150.00% to 0 cents per share on August 12
Q2'26
Est.
$0.00
Q1'26
Est.
$0.01
Q4'25
Beat
by $0.02
Q3'25
Beat
by $0.05
Q2'25
Beat
by $0.03
The last earnings report on May 07 showed earnings per share of 0 cents, meeting the estimate of 0 cents. With 4.40K shares outstanding, the current market capitalization sits at 38.98M.
A.I. Advisor
published General Information
General Information
a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system
A.I.dvisor indicates that over the last year, NEPH has been loosely correlated with SGHT. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if NEPH jumps, then SGHT could also see price increases.
Aroon Indicator for NEPH shows an upward move is likely
NEPH's Aroon Indicator triggered a bullish signal on June 11, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 130 similar instances where the Aroon Indicator showed a similar pattern. In of the 130 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for NEPH just turned positive on June 26, 2026. Looking at past instances where NEPH's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .
NEPH moved above its 50-day moving average on July 09, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for NEPH crossed bullishly above the 50-day moving average on June 30, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NEPH advanced for three days, in of 200 cases, the price rose further within the following month. The odds of a continued upward trend are .
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 42 cases where NEPH's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
The Momentum Indicator moved below the 0 level on July 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NEPH as a result. In of 98 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
NEPH broke above its upper Bollinger Band on June 26, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NEPH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.642) is normal, around the industry mean (4.675). P/E Ratio (51.286) is within average values for comparable stocks, (193.447). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.510). Dividend Yield (0.000) settles around the average of (0.022) among similar stocks. P/S Ratio (2.076) is also within normal values, averaging (83.877).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NEPH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 97, placing this stock worse than average.
